PATIENT TRANSFER FROM HEMODIALYSIS TO PERITONEAL DIALYSIS: A SINGLE CENTER EXPERIENCE

Vedad Herenda, D. Rebić, Senad Hasanspahić, Faris Kadić, A. Hamzić-Mehmedbašić
{"title":"PATIENT TRANSFER FROM HEMODIALYSIS TO PERITONEAL DIALYSIS: A SINGLE CENTER EXPERIENCE","authors":"Vedad Herenda, D. Rebić, Senad Hasanspahić, Faris Kadić, A. Hamzić-Mehmedbašić","doi":"10.35120/medisij020407h","DOIUrl":null,"url":null,"abstract":"INTRODUCTION Peritoneal dialysis and hemodialysis are complementary ways of treating end-stage renal failure. Changing the dialysis modality from hemodialysis to peritoneal dialysis is a rare and poorly studied phenomenon. MATERIALS AND METHODS Retrospective cohort study conducted on the population of adult patients with end-stage chronic renal failure who were treated at the Nephrology Clinic of the Clinical Center of the University of Sarajevo in the period from 2006 to 2023. A total of 109 adult patients, whose medical documentation was complete and who were in the peritoneal dialysis program at the Nephrology Clinic of the Clinical Center of the University of Sarajevo during the observed period, were included in this study. One group started the treatment with peritoneal dialysis, and the other with hemodialysis. Demographic data were collected for each patient: age, gender, underlying kidney disease, comorbidities (heart disease and diabetes), duration of treatment modality, data on modality change, complications and treatment outcomes. Data from physical and electronic patient histories were used. RESULTS Total of 109 adult patients were included in this study. They are divided into two groups. Group 1 (n=99) in which peritoneal dialysis was the first treatment modality and Group 2 (n=10) in which haemodialysis was the first treatment modality, but in which patients, after a certain time, were transferred to peritoneal dialysis. The median age of patients in Group 1 was 60 (-/-14.07) years and 54 (-/+12.23) years for Group 2. Within Group 1 the most common cause of terminal renal failure was diabetic nephropathy (n=40, 40.4%) and nephroangiosclerosis (n=24, 24.24%). The mean age of onset of peritoneal dialysis was 60 (-/-14.07) years, while the mean age of cessation of peritoneal dialysis was 63 (±13.69) years. The average duration of peritoneal dialysis treatment was 38.36(±34.14) months. During the stay at peritoneal dialysis, death was recorded in 63 patients (62.38%). The number of patients who replaced peritoneal dialysis treatment with hemodialysis was 26. The most common reason for switching to haemodialysis was insufficiency of peritoneal dialysis (n=13, 14%). After switching to haemodialysis, the average length of staying on it was 10.22 months. The reason for discontinuation of haemodialysis was death (n=17, ) or transplantation (n=1, 3.7%). Kaplan-Meier test shown worse outcome in patients with haemodialyis first than peritoneal dialysis first. CONCLUSION Changing the dialysis modality carries with it a high risk of mortality, especially in the first month. Changing the way of active treatment with dialysis speaks in favor of severe comorbidities.","PeriodicalId":446210,"journal":{"name":"MEDIS – International Journal of Medical Sciences and Research","volume":"14 3","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-12-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"MEDIS – International Journal of Medical Sciences and Research","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.35120/medisij020407h","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

INTRODUCTION Peritoneal dialysis and hemodialysis are complementary ways of treating end-stage renal failure. Changing the dialysis modality from hemodialysis to peritoneal dialysis is a rare and poorly studied phenomenon. MATERIALS AND METHODS Retrospective cohort study conducted on the population of adult patients with end-stage chronic renal failure who were treated at the Nephrology Clinic of the Clinical Center of the University of Sarajevo in the period from 2006 to 2023. A total of 109 adult patients, whose medical documentation was complete and who were in the peritoneal dialysis program at the Nephrology Clinic of the Clinical Center of the University of Sarajevo during the observed period, were included in this study. One group started the treatment with peritoneal dialysis, and the other with hemodialysis. Demographic data were collected for each patient: age, gender, underlying kidney disease, comorbidities (heart disease and diabetes), duration of treatment modality, data on modality change, complications and treatment outcomes. Data from physical and electronic patient histories were used. RESULTS Total of 109 adult patients were included in this study. They are divided into two groups. Group 1 (n=99) in which peritoneal dialysis was the first treatment modality and Group 2 (n=10) in which haemodialysis was the first treatment modality, but in which patients, after a certain time, were transferred to peritoneal dialysis. The median age of patients in Group 1 was 60 (-/-14.07) years and 54 (-/+12.23) years for Group 2. Within Group 1 the most common cause of terminal renal failure was diabetic nephropathy (n=40, 40.4%) and nephroangiosclerosis (n=24, 24.24%). The mean age of onset of peritoneal dialysis was 60 (-/-14.07) years, while the mean age of cessation of peritoneal dialysis was 63 (±13.69) years. The average duration of peritoneal dialysis treatment was 38.36(±34.14) months. During the stay at peritoneal dialysis, death was recorded in 63 patients (62.38%). The number of patients who replaced peritoneal dialysis treatment with hemodialysis was 26. The most common reason for switching to haemodialysis was insufficiency of peritoneal dialysis (n=13, 14%). After switching to haemodialysis, the average length of staying on it was 10.22 months. The reason for discontinuation of haemodialysis was death (n=17, ) or transplantation (n=1, 3.7%). Kaplan-Meier test shown worse outcome in patients with haemodialyis first than peritoneal dialysis first. CONCLUSION Changing the dialysis modality carries with it a high risk of mortality, especially in the first month. Changing the way of active treatment with dialysis speaks in favor of severe comorbidities.
病人从血液透析转到腹膜透析:一个中心的经验
简介 腹膜透析和血液透析是治疗终末期肾衰竭的互补方式。将透析方式从血液透析改为腹膜透析是一种罕见的现象,对这种现象的研究也不多。材料和方法 对 2006 年至 2023 年期间在萨拉热窝大学临床中心肾脏病诊所接受治疗的终末期慢性肾衰竭成年患者进行了回顾性队列研究。本研究共纳入了 109 名成年患者,这些患者的医疗文件齐全,且在观察期内在萨拉热窝大学临床中心肾脏病诊所接受腹膜透析治疗。其中一组患者开始接受腹膜透析治疗,另一组患者开始接受血液透析治疗。研究人员收集了每位患者的人口统计学数据:年龄、性别、基础肾病、合并症(心脏病和糖尿病)、治疗方式持续时间、治疗方式变更数据、并发症和治疗效果。此外,还使用了患者的体格检查和电子病历数据。结果 本研究共纳入 109 名成年患者。他们被分为两组。第一组(人数=99)以腹膜透析为第一治疗方式,第二组(人数=10)以血液透析为第一治疗方式,但患者在一段时间后转为腹膜透析。第一组患者的中位年龄为 60(-/-14.07)岁,第二组患者的中位年龄为 54(-/+12.23)岁。在第一组中,导致终末期肾衰竭的最常见原因是糖尿病肾病(40 人,占 40.4%)和肾血管硬化(24 人,占 24.24%)。开始腹膜透析的平均年龄为 60(-/-14.07)岁,停止腹膜透析的平均年龄为 63(±13.69)岁。腹膜透析治疗的平均持续时间为 38.36(±34.14)个月。在腹膜透析期间,有 63 名患者(62.38%)死亡。以血液透析取代腹膜透析治疗的患者有 26 人。改用血液透析的最常见原因是腹膜透析效果不佳(13 人,14%)。转为血液透析后,平均住院时间为 10.22 个月。停止血液透析的原因是死亡(17 人)或移植(1 人,3.7%)。Kaplan-Meier 检验显示,先进行血液透析的患者比先进行腹膜透析的患者预后更差。结论 改变透析方式有很高的死亡风险,尤其是在第一个月。改变透析的积极治疗方式有利于合并症严重的患者。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信